Your browser doesn't support javascript.
loading
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
Sridhar, Saranya; Joaquin, Arnel; Bonaparte, Matthew I; Bueso, Agustin; Chabanon, Anne-Laure; Chen, Aiying; Chicz, Roman M; Diemert, David; Essink, Brandon J; Fu, Bo; Grunenberg, Nicole A; Janosczyk, Helene; Keefer, Michael C; Rivera M, Doris M; Meng, Ya; Michael, Nelson L; Munsiff, Sonal S; Ogbuagu, Onyema; Raabe, Vanessa N; Severance, Randall; Rivas, Enrique; Romanyak, Natalya; Rouphael, Nadine G; Schuerman, Lode; Sher, Lawrence D; Walsh, Stephen R; White, Judith; von Barbier, Dalia; de Bruyn, Guy; Canter, Richard; Grillet, Marie-Helene; Keshtkar-Jahromi, Maryam; Koutsoukos, Marguerite; Lopez, Denise; Masotti, Roger; Mendoza, Sandra; Moreau, Catherine; Ceregido, Maria Angeles; Ramirez, Shelly; Said, Ansoyta; Tavares-Da-Silva, Fernanda; Shi, Jiayuan; Tong, Tina; Treanor, John; Diazgranados, Carlos A; Savarino, Stephen.
Afiliación
  • Sridhar S; Sanofi Pasteur, Reading, UK. Electronic address: saranya.sridhar@sanofi.com.
  • Joaquin A; Charles R Drew University of Medicine and Science, Los Angeles, CA, USA.
  • Bonaparte MI; Sanofi Pasteur, Swiftwater, PA, USA.
  • Bueso A; Demedica, San Pedro Sula, Honduras.
  • Chabanon AL; Sanofi Pasteur, Lyon, France.
  • Chen A; Sanofi Pasteur, Swiftwater, PA, USA.
  • Chicz RM; Sanofi Pasteur, Cambridge, MA, USA.
  • Diemert D; The George Washington School of Medicine and Health Sciences, Washington, DC, USA.
  • Essink BJ; Meridian Clinical Research, Omaha, NE, USA.
  • Fu B; Sanofi Pasteur, Swiftwater, PA, USA.
  • Grunenberg NA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Janosczyk H; Sanofi Pasteur, Swiftwater, PA, USA.
  • Keefer MC; University of Rochester, School of Medicine and Dentistry, Rochester, NY, USA.
  • Rivera M DM; INVERIME, Tegucigalpa, Honduras.
  • Meng Y; Sanofi Pasteur, Swiftwater, PA, USA.
  • Michael NL; Walter Reed Army Institute of Research, Silver Spring, MD, USA.
  • Munsiff SS; University of Rochester, School of Medicine and Dentistry, Rochester, NY, USA.
  • Ogbuagu O; Yale University School of Medicine, New Haven, CT, USA.
  • Raabe VN; New York University Grossman School of Medicine, New York, NY, USA.
  • Severance R; Synexus Clinical Research Limited, Tempe, AZ, USA.
  • Rivas E; Sanofi Pasteur, Ciudad de México, Mexico.
  • Romanyak N; Sanofi Pasteur, Swiftwater, PA, USA.
  • Rouphael NG; Emory University School of Medicine, Atlanta, GA, USA.
  • Schuerman L; GlaxoSmithKline Vaccines, Wavre, Belgium.
  • Sher LD; Peninsula Research Associates, Rolling Hills Estates, CA, USA.
  • Walsh SR; Harvard Medical School, Boston, MA, USA.
  • White J; Synexus, Orlando, FL, USA.
  • von Barbier D; Sanofi Pasteur, Swiftwater, PA, USA.
  • de Bruyn G; Sanofi Pasteur, Swiftwater, PA, USA.
  • Canter R; Sanofi Pasteur, Swiftwater, PA, USA.
  • Grillet MH; Sanofi Pasteur, Lyon, France.
  • Keshtkar-Jahromi M; National Institute of Health (NIH), Rockville, MD, USA.
  • Koutsoukos M; GlaxoSmithKline Vaccines, Wavre, Belgium.
  • Lopez D; Sanofi Pasteur, Swiftwater, PA, USA.
  • Masotti R; Sanofi Pasteur, Swiftwater, PA, USA.
  • Mendoza S; Sanofi Pasteur, Bogota, Colombia.
  • Moreau C; Sanofi Pasteur, Marcy l'Etoile, France.
  • Ceregido MA; GlaxoSmithKline Vaccines, Wavre, Belgium.
  • Ramirez S; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Said A; Sanofi Pasteur, Marcy l'Etoile, France.
  • Tavares-Da-Silva F; GlaxoSmithKline Vaccines, Wavre, Belgium.
  • Shi J; TechData Service Company, King of Prussia, PA, USA.
  • Tong T; Vaccine Translational Research Branch, National Institute of Allergy and Infectious Diseases, NIH, Rockville, MD, USA.
  • Treanor J; Biomedical Advanced Research and Development Authority, Washington, DC, USA.
  • Diazgranados CA; Sanofi Pasteur, Swiftwater, PA, USA.
  • Savarino S; Sanofi Pasteur, Swiftwater, PA, USA.
Lancet Infect Dis ; 22(5): 636-648, 2022 05.
Article en En | MEDLINE | ID: mdl-35090638
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline Límite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline Límite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article